These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 8622618)

  • 1. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(22):468-80. PubMed ID: 8622618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV infection and acquired immunodeficiency syndrome].
    Takamatsu J
    Rinsho Byori; 1997 May; 45(5):409-14. PubMed ID: 9170967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From the Centers for Disease Control and Prevention. Update: provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV.
    JAMA; 1996 Jul; 276(2):90-2. PubMed ID: 8656516
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for reducing the risk of occupational HIV transmission.
    Paul SM
    N J Med; 2003 Sep; 100(9 Suppl):15-20; quiz 65-6. PubMed ID: 14556598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and recommendations for HIV occupational exposures.
    Paul SM; Costa SJ; Ziskin LZ
    MLO Med Lab Obs; 1998 Sep; 30(9):58-60, 62-6, 70. PubMed ID: 10186318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of the Occupational Safety and Health Administration's bloodborne pathogen standard for the occupational health professional.
    Udasin IG; Gochfeld M
    J Occup Med; 1994 May; 36(5):548-55. PubMed ID: 8027880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHS recommends preventive drugs for HIV exposures.
    OR Manager; 1996 Aug; 12(8):1, 6. PubMed ID: 10161372
    [No Abstract]   [Full Text] [Related]  

  • 9. Occupational exposure to blood and body fluids: new postexposure prophylaxis recommendations. United States Occupational Safety and Health Administration.
    Cuny E; Carpenter WM
    J Calif Dent Assoc; 1998 Apr; 26(4):261-7, 269-71. PubMed ID: 9709639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and management of occupational exposures to human immunodeficiency virus (HIV).
    Calfee DP
    Mt Sinai J Med; 2006 Oct; 73(6):852-6. PubMed ID: 17117310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-exposure prophylaxis for human immunodeficiency virus infection in the Royal Infirmary of Edinburgh--an audit.
    Manavi K; McMillan A; Paterson J
    Int J STD AIDS; 2004 Feb; 15(2):134-8. PubMed ID: 15006077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New guidelines issued for occupational exposures.
    AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use.
    Can Dis Wkly Rep; 1990 Nov; 16 Suppl 2():4-13. PubMed ID: 2292114
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
    Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of occupational exposures to bloodborne viruses: HIV post-exposure prophylaxis.
    Verhagen C
    J Mich Dent Assoc; 1999 Sep; 81(7):16, 44-6. PubMed ID: 10808350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postexposure prophylaxis for HIV.
    Daily JP
    AIDS Clin Care; 1997 Aug; 9(8):59-61, 66. PubMed ID: 11364478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV prone occupational exposures: epidemiology and factors associated with initiation of post-exposure prophylaxis.
    Zenner D; Tomkins S; Charlett A; Wellings K; Ncube F
    J Epidemiol Community Health; 2009 May; 63(5):373-8. PubMed ID: 19188197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.